Literature DB >> 21731058

The potential influence of KIR cluster profiles on disease patterns of Canadian Aboriginals and other indigenous peoples of the Americas.

Julia D Rempel1, Kim Hawkins, Erin Lande, Peter Nickerson.   

Abstract

Genetic differences in immune regulators influence disease resistance and susceptibility patterns. There are major health discrepancies in immune-mediated diseases between Caucasians and Canadian Aboriginal people, as well as with other indigenous people of the Americas. Environmental factors offer a limited explanation as Aboriginal people also demonstrate a rare resistance to chronic hepatitis C virus infection. Killer immunoglobulin-like receptors (KIRs) are known modulators of viral responses and autoimmune diseases. The possibility that variation in KIR cluster profiles contribute to the health outcomes of Aboriginal people was evaluated with Canadian Caucasian (n=93, population controls) and Aboriginal (n=86) individuals. Relative to Caucasians, the Aboriginal KIR cluster displayed a greater immune activating phenotype associated with genes of the B haplotype situated within the telomeric region. In conjunction, there was a decrease in the genes of the B haplotype from the centromeric region. Caucasian and Aboriginal cohorts further demonstrated distinct genotype and haplotype relationships enforcing the disconnect between the B haplotype centromeric and telomeric regions within the Aboriginal population. Moreover, Caucasian KIR cluster patterns reflected studies of Caucasians globally, as well as Asians. In contrast, the unique pattern of the Canadian Aboriginal cohort mirrored the phenotype of other indigenous peoples of the Americas, but not that of Caucasians or Asians. Taken together, these data suggest that historically indigenous peoples of the Americas were subject to immune selection processes that could be influencing the current disease resistance and susceptibility patterns of their descendents.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21731058      PMCID: PMC3230357          DOI: 10.1038/ejhg.2011.114

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  43 in total

1.  The major epidemic infections: a gift from the Old World to the New?

Authors:  R Sessa; C Palagiano; M G Scifoni; M di Pietro; M Del Piano
Journal:  Panminerva Med       Date:  1999-03       Impact factor: 5.197

2.  Hepatitis C virus infection among First Nation and non-First Nation people in Manitoba, Canada: a public health laboratory study.

Authors:  Magdy Dawood; Gerry Smart; Michelyn Wood; Hong-Xing Wu; Shirley Paton; Jun Wu
Journal:  Can J Microbiol       Date:  2006-10       Impact factor: 2.419

3.  The persistence of American Indian health disparities.

Authors:  David S Jones
Journal:  Am J Public Health       Date:  2006-10-31       Impact factor: 9.308

4.  The first smallpox epidemic on the Canadian Plains: In the fur-traders' words.

Authors:  C S Houston; S Houston
Journal:  Can J Infect Dis       Date:  2000-03

5.  Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection.

Authors:  Antonio López-Vázquez; Luis Rodrigo; Jesus Martínez-Borra; Ramón Pérez; Manuel Rodríguez; Juan L Fdez-Morera; Dolores Fuentes; Sandra Rodríguez-Rodero; Segundo Gonzáez; Carlos López-Larrea
Journal:  J Infect Dis       Date:  2005-05-25       Impact factor: 5.226

6.  The influence of North American Aboriginal ethnicity on pro-inflammatory and anti-inflammatory cytokine responses to IFN-alpha.

Authors:  J D Rempel; K B Aborsangaya; M P Alphonse; G Y Minuk
Journal:  J Viral Hepat       Date:  2008-10-17       Impact factor: 3.728

7.  HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.

Authors:  Salim I Khakoo; Chloe L Thio; Maureen P Martin; Collin R Brooks; Xiaojiang Gao; Jacquie Astemborski; Jie Cheng; James J Goedert; David Vlahov; Margaret Hilgartner; Steven Cox; Ann-Margeret Little; Graeme J Alexander; Matthew E Cramp; Stephen J O'Brien; William M C Rosenberg; David L Thomas; Mary Carrington
Journal:  Science       Date:  2004-08-06       Impact factor: 47.728

8.  KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.

Authors:  A C Flores; C Y Marcos; N Paladino; M Capucchio; G Theiler; L Arruvito; R Pardo; A Habegger; F Williams; D Middleton; L Fainboim
Journal:  Tissue Antigens       Date:  2007-06

9.  Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users.

Authors:  Jason Grebely; Jesse D Raffa; Calvin Lai; Mel Krajden; Brian Conway; Mark W Tyndall
Journal:  Can J Gastroenterol       Date:  2007-07       Impact factor: 3.522

10.  Elevated rates of HIV infection among young Aboriginal injection drug users in a Canadian setting.

Authors:  Cari L Miller; Steffanie A Strathdee; Patricia M Spittal; Thomas Kerr; Kathy Li; Martin T Schechter; Evan Wood
Journal:  Harm Reduct J       Date:  2006-03-08
View more
  9 in total

1.  Enrichment of variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU patients: an exploratory study.

Authors:  David La; Chris Czarnecki; Hani El-Gabalawy; Anand Kumar; Adrienne F A Meyers; Nathalie Bastien; J Neil Simonsen; Francis A Plummer; Ma Luo
Journal:  PLoS One       Date:  2011-12-28       Impact factor: 3.240

2.  Favourable IFNL3 genotypes are associated with spontaneous clearance and are differentially distributed in Aboriginals in Canadian HIV-hepatitis C co-infected individuals.

Authors:  Nasheed Moqueet; Claire Infante-Rivard; Robert W Platt; Jim Young; Curtis Cooper; Mark Hull; Sharon Walmsley; Marina B Klein
Journal:  Int J Mol Sci       Date:  2015-03-20       Impact factor: 5.923

3.  KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians.

Authors:  Louis-Marie Yindom; Maimuna Mendy; Christopher Bodimeade; Caroline Chambion; Peter Aka; Hilton C Whittle; Sarah L Rowland-Jones; Robert Walton
Journal:  PLoS One       Date:  2017-11-17       Impact factor: 3.240

4.  Effect of vitamin D supplementation on Mycobacterium tuberculosis-induced innate immune responses in a Canadian Dené First Nations cohort.

Authors:  Linda Larcombe; Pamela Orr; Emily Turner-Brannen; Caroline R Slivinski; Peter W Nickerson; Neeloffer Mookherjee
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

Review 5.  Hepatitis C virus in American Indian/Alaskan Native and Aboriginal peoples of North America.

Authors:  Julia D Rempel; Julia Uhanova
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

6.  Preliminary analysis of immune activation in early onset type 2 diabetes.

Authors:  Julia D Rempel; Juliet Packiasamy; Heather J Dean; Jonathon McGavock; Alyssa Janke; Mark Collister; Brandy Wicklow; Elizabeth A C Sellers
Journal:  Int J Circumpolar Health       Date:  2013-08-05       Impact factor: 1.228

7.  Killer immunoglobulin-like receptor (KIR) centromeric-AA haplotype is associated with ethnicity and tuberculosis disease in a Canadian First Nations cohort.

Authors:  Kali Braun; Linda Larcombe; Pamela Orr; Peter Nickerson; Joyce Wolfe; Meenu Sharma
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

8.  Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations Patients.

Authors:  Julia Uhanova; Gerald Minuk; Federico Lopez Ficher; Natasha Chandok
Journal:  Can J Gastroenterol Hepatol       Date:  2016-04-28

9.  Distribution of Hepatitis C Risk Factors and HCV Treatment Outcomes among Central Canadian Aboriginal.

Authors:  Parmvir Parmar; Daniel J Corsi; Curtis Cooper
Journal:  Can J Gastroenterol Hepatol       Date:  2016-04-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.